GSK TURKEY RX ZET

Company Introduction for GSK TURKEY RX ZET

Nature of Business: Manufacturer

Company Profile:

GSK TURKEY RX ZET refers to the operations of GlaxoSmithKline (GSK) in Turkey, specifically within its prescription pharmaceuticals (RX) division. GSK is a prominent global pharmaceutical and healthcare company that researches, develops, manufactures, and markets a broad portfolio of innovative medicines, vaccines, and consumer healthcare products.

In Turkey, GSK serves as a vital part of its global network, responsible for the marketing, sales, and distribution of its pharmaceutical products. While the primary manufacturing occurs at various global GSK facilities, the Turkish entity directly manages the supply chain, local regulatory affairs, and commercial activities to ensure these manufactured products reach patients and healthcare providers across Turkey. Depending on operational strategies, the Turkish operations may also include local secondary manufacturing processes such as packaging and labeling.

The company is deeply committed to advancing healthcare in Turkey by providing access to its globally manufactured medicines and vaccines, contributing to public health, and engaging in ethical business practices. Its classification as a manufacturer stems from its integral role as the local arm of a global pharmaceutical manufacturing giant.

GSK Turkey RX Zet manufactures or markets the following products:

* **Augmentin** (Amoxicillin/Clavulanate)

* **Amoxil** (Amoxicillin)

* **Bactroban** (Mupirocin)

* **Corega** (Denture Fixative)

* **Lamisil** (Terbinafine)

* **Parol** (Paracetamol)

* **Genotropin** (Somatropin)

* **Zinnat** (Cefuroxime Axetil)

* **Ceftine** (Cefuroxime Axetil)